Showing results (131-140 of 752) with videos related to

Sort By:
Pageof 76
Neuro-Oncology Advances|December 23, 2024
Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade gliomaCrismita Dmello, Andrew Brenner, David Piccioni, et al.
Neuro-Oncology Advances|October 13, 2022
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningiomaPriya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, et al.
The Lancet. Oncology|January 2, 2007
Part I: spinal-cord neoplasms-intradural neoplasmsDavid E Traul, Mark E Shaffrey, David Schiff
Plos One|March 14, 2014
MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and METYing Zhang, David Schiff, Deric Park, et al.
Neurologic Clinics|August 4, 2018
Neurologic and Medical Management of Brain TumorsKester A Phillips, Camilo E Fadul, David Schiff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2023
Bevacizumab Alone and in Combination With Irinotecan in Recurrent GlioblastomaHenry S Friedman, Michael D Prados, Patrick Y Wen, et al.
Expert Review of Anticancer Therapy|April 27, 2013
A model for the regulation of T-type Ca(2+) channels in proliferation: roles in stem cells and cancerLloyd S Gray, David Schiff, Timothy L Macdonald
Seminars in Thrombosis and Hemostasis|March 7, 2014
Thrombosis in brain tumorsJasmin T Jo, David Schiff, James R Perry
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Bevacizumab alone and in combination with irinotecan in recurrent glioblastomaHenry S Friedman, Michael D Prados, Patrick Y Wen, et al.
Neuro-Oncology|October 16, 2025
Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant GliomasDavid Schiff, Xiaobu Ye, Jing Li, et al.
Pageof 76